Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Functional electrical stimulation plus physiotherapy for severe post-stroke ICU-acquired weakness

Official title: Intensive Rehabilitation by Functional Electrical Stimulation for the Treatment of Critical Neuromyopathy in Patients With Severe Stroke Admitted to the Highly Specialized Intensive Rehabilitation Unit: a Pilot Study

Run by Fondazione Don Carlo Gnocchi ETS · NCT07130929 · Data updated 2026-11-12

This pilot will try using functional electrical stimulation together with physiotherapy to help adults with recent severe stroke who developed ICU-acquired weakness regain strength and movement.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment24 (estimated)
SponsorFondazione Don Carlo Gnocchi ETS
Academic / other
Locations1 site (Florence, FI)
StatusRecruiting
StartedSeptember 23, 2025
Main results expectedSeptember 23, 2026
Study endsMarch 23, 2027
Registry record updatedDecember 11, 2025
Trial IDNCT07130929 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–80 with ischemic or hemorrhagic stroke within three months, premorbid mRS <2, cognitive ability for active participation, clinical and neurophysiological confirmation of ICU‑AW with MRC sum ≤48, and no contraindications to FES.

Probably not a fit

Patients with hemodynamic or respiratory instability, uncontrolled epilepsy, implanted electronic devices, severe spasticity (>3), chronic neuropathy, skin integrity problems at electrode sites, pregnancy or breastfeeding, or other listed exclusions are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot enrolls a small group of adults with severe acquired brain injury from ischemic or hemorrhagic stroke who have a clinical and neurophysiological diagnosis of ICU-acquired weakness. Participants receive conventional physiotherapy sessions augmented by surface functional electrical stimulation (FES) applied to target muscles while they actively perform motor tasks under physiotherapist supervision. The combined approach aims to promote neuroplasticity and muscle reactivation by pairing repetitive, task-oriented movement with timed electrical stimulation. Outcomes will focus on changes in muscle strength, motor function, and relevant neurophysiological measures over the treatment period.

Why it matters

Potential benefit: If successful, this approach could speed recovery of muscle strength and improve functional mobility after severe stroke-related ICU-acquired weakness.

How similar studies have gone: FES has shown positive signals for strength and function in other post-stroke and ICU rehabilitation programs, but high-quality evidence specifically in severe ICU‑AW is limited and this application remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of ischemic or hemorrhagic vascular GCA involving unilateral motor deficit \< 3 months;
* Premorbid Modified Rankin Scale \<2;
* Age \>18 years and \<80 years;
* Level of Cognitive Functioning \> 4 for active participation in treatment.
* MRC total sum score \<= 48 (range 0 -60) for clinical suspicion of ICU-AW
* Clinical diagnosis of tetra/paraparesis of peripheral origin confirmed by neurophysiological examination;
* Signature of informed consent by the patient or, if incapacitated, by their legal representative.

Exclusion Criteria:

* Clinical cardio-respiratory or internal instability such as to prevent treatment;
* History of previous comorbidity for ICU-AW;
* Previous known chronic neuropathy;
* Severe coagulopathy;
* Skin integrity problems at the interface surfaces with the electrostimulator;
* Epilepsy not controlled by medication;
* Presence of implanted electronic devices;
* Pregnancy or breastfeeding;
* Severe spasticity with a score of \>3 on the modified Ashworth scale;
* Treatment with botulinum toxin;
* Recent malignant neoplasm;
* Conditions that put you at risk for neuropathies, e.g., history of diabetes mellitus, renal failure, hepatic failure, vitamin deficiencies, chronic alcoholism, vasculitis, previous use of neurotoxic drugs.

Where it's running

  • IRCCS-Fondazione Don Gnocchi
    Florence, Fi, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.